Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; Instituto Nacional de Saúde (INS), Ministério da Saúde, Maputo, Mozambique.
World Health Organization (WHO), Inter Country Support Team (IST), Harare, Zimbabwe.
Vaccine. 2021 May 27;39(23):3111-3119. doi: 10.1016/j.vaccine.2021.03.021. Epub 2021 May 3.
The World Health Organization (WHO) recommended the worldwide use of rotavirus vaccines initially in 2007 and 2009 applying a strict age restriction criterion due to the potential for age-related association with increased risk of intussusception in infants. The restriction was relaxed in the 2013 after detailed review of robust safety data generated in post-marketing surveillance studies. We assessed the status of the implementation of the 2013 recommendation to remove age restriction in the WHO African region (AFR). Of the approximately 75% (35/47) of countries that had introduced the vaccine by 2018, only 43% (15/35) removed age restriction, exclusively from South and East sub-region (78%, 14/18). Avoiding confusion at the health facilities and financial constraints particularly resources required for re-training the health workers, use of vaccine off-label were cited as the main reasons for not implementing the 2013 WHO recommendation on age restriction removal. The 2013 WHO recommendation has not been fully implemented by African countries, suggesting the need for technical advisory bodies to further guide the countries, continue monitoring the implementation status and impact on the rotavirus vaccine coverage and intussusception in the Africa region.
世界卫生组织(WHO)最初于 2007 年和 2009 年推荐在全球范围内使用轮状病毒疫苗,并由于婴儿肠套叠风险与年龄相关,因此应用了严格的年龄限制标准。在详细审查了上市后监测研究中产生的可靠安全性数据后,该限制于 2013 年放宽。我们评估了在世界卫生组织非洲区域(AFR)实施取消年龄限制的 2013 年建议的状况。在 2018 年引入疫苗的约 75%(35/47)的国家中,只有 43%(15/35)取消了年龄限制,仅限于南部和东部次区域(78%,14/18)。避免在卫生机构中产生混淆以及财务限制,特别是重新培训卫生工作者所需的资源,被认为是不执行 2013 年关于取消年龄限制的世卫组织建议的主要原因。非洲国家尚未全面执行 2013 年世卫组织的建议,这表明需要技术咨询机构进一步指导各国,继续监测实施状况及其对非洲地区轮状病毒疫苗覆盖率和肠套叠的影响。